Overactive Bladder
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with overactive bladder resistant to the standard therapies (behavior therapy, antimuscarinics, beta3 receptor agonist, etc.) 2. Patients with overactive bladder having difficulty with continuation of medical therapy because of side effects or co-morbidities 3. Patients who are able to understand the nature of study and give written informed consent 4. Patients who have willingness and ability to comply with the study protocol for the duration of the study
Exclusion criteria
Exclusion criteria: 1. Patients with cardiac pacemakers 2. Patients with severe arrhythmia (AV block, etc.) 3. Patients with severe heart disease 4. Patients with venous/arterial thrombosis or thrombophlebitis of lower extremities 5. Patients with skin disorder (injury, scar, skin disease, malignancy, etc.) on the lower extremities 6. Pregnant women 7. Patients with history of convulsion or patients seizures are predicted 8. Patients with excessive post-void residual volume (100 ml and more) 9. Patients with bladder disorders (calculus, cancer, tuberculosis, chronic bacterial cystitis, radiation cystitis, etc.) 10. Any condition which in the judgment of the investigator would place the patient inappropriate to be enrolled in this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) Assess the improvement in the following questionnaire 1. International Prostate Symptom Score and QOL index 2. Overactive Bladder Symptom Score 3. Core lower urinary tract symptom score 4. King's Health Questionnaire, Japanese edition 2) Assess the improvement in the frequency-volume chart voiding frequency, voiding volume, nocturnal polyuria index (NPi) 3) Assess the improvement in the urodynamic study parameters 1. uroflowmetry parameters, post-void residual volume 2. cystometric parameters | — |
Countries
Japan
Contacts
University of Fukui Department of Urology